Community pharmaceuticals - expenditure trends

24 November 2017

A review of community pharmaceutical expenditure trends shows a drop in the proportion of the health budget devoted to pharmaceutical purchasing.  Inflation, population growth and a widening of purchase responsibility means that PHARMAC has effectively a little more than half the portion of the health budget it had a decade ago for community pharmaceuticals. PHARMAC needs a $600m boost to keep up with the increase in funding to DHBs.

Read the report here.